Metropolitan Life Insurance CO Verastem, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.02 - $1.83 $12,447 - $22,331	-12,203 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$1.06 - $2.1 $12,935 - $25,626	12,203 New	12,203 $17,000
Q1 2022 Mar 30, 2023	SELL	$1.06 - $2.1 $18,646 - $36,941	-17,591 Reduced 59.04%	12,203 $17,000
Q1 2022 May 12, 2022	SELL	$1.06 - $2.1 $18,646 - $36,941	-17,591 Reduced 59.04%	12,203 $17,000
Q4 2021 Jun 21, 2023	BUY	$2.05 - $3.2 $61,077 - $95,340	29,794 New	29,794 $61,000
Q4 2021 Mar 30, 2023	BUY	$2.05 - $3.2 $25,639 - $40,022	12,507 Added 72.35%	29,794 $61,000
Q4 2021 Feb 15, 2022	BUY	$2.05 - $3.2 $25,639 - $40,022	12,507 Added 72.35%	29,794 $61,000
Q3 2021 Jun 21, 2023	BUY	$2.54 - $4.07 $43,908 - $70,358	17,287 New	17,287 $53,000
Q3 2021 Mar 30, 2023	SELL	$2.54 - $4.07 $44,828 - $71,831	-17,649 Reduced 50.52%	17,287 $53,000
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $44,828 - $71,831	-17,649 Reduced 50.52%	17,287 $53,000
Q2 2021 Jun 21, 2023	BUY	$2.57 - $4.85 $89,785 - $169,439	34,936 New	34,936 $142,000
Q2 2021 Mar 30, 2023	SELL	$2.57 - $4.85 $46,105 - $87,009	-17,940 Reduced 33.93%	34,936 $142,000
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $89,649 - $169,182	34,883 Added 65816.98%	34,936 $142,000
Q1 2021 Jun 26, 2023	BUY	$1.9 - $2.82 $100,464 - $149,110	52,876 New	52,876 $131 Million
Q1 2021 Mar 30, 2023	BUY	$1.9 - $2.82 $7,444 - $11,048	3,918 Added 8.0%	52,876 $130,000
Q1 2021 May 14, 2021	SELL	$1.9 - $2.82 $92,919 - $137,912	-48,905 Reduced 99.89%	53 $131,000
Q4 2020 Jun 22, 2023	BUY	$1.15 - $2.4 $56,301 - $117,499	48,958 New	48,958 $104,000
Q4 2020 Mar 30, 2023	SELL	$1.15 - $2.4 $578 - $1,207	-503 Reduced 1.02%	48,958 $104,000
Q4 2020 Feb 16, 2021	SELL	$1.15 - $2.4 $578 - $1,207	-503 Reduced 1.02%	48,958 $104,000
Q3 2020 Jun 26, 2023	BUY	$1.11 - $1.68 $54,901 - $83,094	49,461 New	49,461 $59,000
Q3 2020 Mar 30, 2023	SELL	$1.11 - $1.68 $7,034 - $10,646	-6,337 Reduced 11.36%	49,461 $59,000
Q3 2020 Nov 13, 2020	SELL	$1.11 - $1.68 $7,034 - $10,646	-6,337 Reduced 11.36%	49,461 $60,000
Q2 2020 Jun 26, 2023	BUY	$1.69 - $4.2 $94,298 - $234,351	55,798 New	55,798 $95,000
Q2 2020 Mar 30, 2023	BUY	$1.69 - $4.2 $94,298 - $234,351	55,798 New	55,798 $95,000
Q2 2020 Aug 14, 2020	BUY	$1.69 - $4.2 $94,298 - $234,351	55,798 New	55,798 $96,000
Q1 2019 May 15, 2019	SELL	$2.79 - $4.09 $65,679 - $96,282	-23,541 Closed	0 $0
Q4 2018 Jul 13, 2023	BUY	$3.23 - $7.01 $76,037 - $165,022	23,541 New	23,541 $79,000
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $59,383 - $128,878	18,385 Added 356.57%	23,541 $79,000
Q3 2018 Jul 13, 2023	BUY	$6.86 - $9.97 $161,491 - $234,703	23,541 New	23,541 $171 Million
Q3 2018 Nov 14, 2018	SELL	$6.86 - $9.97 $93,940 - $136,529	-13,694 Reduced 72.65%	5,156 $37,000
Q2 2018 Aug 15, 2018	BUY	$2.88 - $8.67 $54,288 - $163,429	18,850 New	18,850 $0

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.28 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$274,080
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$114,200
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$17,044
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$6,132
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.2B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account